[HTML][HTML] Detection of plasma cell disorders by mass spectrometry: a comprehensive review of 19,523 cases

S Dasari, MC Kohlhagen, A Dispenzieri… - Mayo Clinic …, 2022 - Elsevier
… (Ig) light chain (LC) mass to charge (m/z) distributions to detect and track M-proteins. This
technique was later adapted to … Dr Dasari and Ms Kohlhagen contributed equally to this work. …

The utility of MASS‐FIX to detect and monitor monoclonal proteins in the clinic

…, DR Barnidge, MC Kohlhagen… - American journal of …, 2017 - Wiley Online Library
… between light-chain m/z of serum and m/z in the … m/z regions containing LC ions. Dotted
lines (in all the figures) identified the m/z ranges of lambda light chains according to Kohlhagen

Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT

…, MC Kohlhagen, NP Splinter, M Christ… - Blood, The Journal …, 2022 - ashpublications.org
… In the spectra, green represents the distribution of all λ-containing Ig's, red represents the
+11 m/z distribution of all κ-containing Ig's, and blue represents the +11 m/z light chain …

[HTML][HTML] An apple a day–how the platform economy impacts value creation in the healthcare market

A Gleiss, M Kohlhagen, K Pousttchi - Electronic Markets, 2021 - Springer
The healthcare industry has been slow to adopt new technologies and practices. However,
digital and data-enabled innovations diffuse the market, and the COVID-19 pandemic has …

Comprehensive assessment of M-proteins using nanobody enrichment coupled to MALDI-TOF mass spectrometry

JR Mills, MC Kohlhagen, S Dasari… - Clinical …, 2016 - academic.oup.com
BACKGROUND Electrophoretic separation of serum and urine proteins has played a central
role in diagnosing and monitoring plasma cell disorders. Despite limitations in resolution …

Technology impact types for digital transformation

…, A Gleiss, B Buzzi, M Kohlhagen - 2019 IEEE 21st …, 2019 - ieeexplore.ieee.org
Digital transformation is based on direct and indirect effects of the application of digital
technologies and techniques on organizational and economic conditions on the one hand and …

Monitoring IgA multiple myeloma: immunoglobulin heavy/light chain assays

JA Katzmann, MAV Willrich, MC Kohlhagen… - Clinical …, 2015 - academic.oup.com
… -spike and the healthy β peak, it is difficult to accurately fractionate the M-spike, and only
41 samples had both an M-spike and an abnormal rHLC. These 41 samples were used to …

A universal solution for eliminating false positives in myeloma due to therapeutic monoclonal antibody interference

JR Mills, MC Kohlhagen, MAV Willrich… - Blood, The Journal …, 2018 - ashpublications.org
… therapy that had M-protein concentrations of ∼0.1 – 0.3 g/dL that persisted after several
months of daratumumab therapy; miRAMM indicated that the M-protein concentration continued …

Automation and validation of a MALDI-TOF MS (Mass-Fix) replacement of immunofixation electrophoresis in the clinical lab

M Kohlhagen, S Dasari, M Willrich… - Clinical Chemistry and …, 2021 - degruyter.com
… to document more M-proteins by Mass-Fix in the PEL/IFE negative cohort. To document the
range of concentrations of M-proteins detected by this method, we documented the largest M-…

[HTML][HTML] MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patients

PW Mellors, S Dasari, MC Kohlhagen, T Kourelis… - Blood cancer …, 2021 - nature.com
Immunoenrichment-based matrix assisted laser desorption ionization time-of-flight mass
spectrometry (MALDI-TOF-MS), termed MASS-FIX, offers several advantages over …